Notable Labs, Ltd. (NTBLQ)

Market Cap	1.45M
Revenue (ttm)	313.00K
Net Income (ttm)	-10.54M
Shares Out	9.66M
EPS (ttm)	-1.42
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,341
Open	0.150
Previous Close	0.180
Day's Range	0.135 - 0.160
52-Week Range	0.100 - 4.240
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About Notable Labs

Notable Labs, Ltd., a clinical-stage platform therapeutics company, develops predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PPMP), bio-simulates a cancer treatment and predicts, whether or not the patient will clinically respond to their actual treatment. Its PPMP is designed to identify and select clinically responsive patients prior to their treatment and enables fast-track therapeutic development in this patient population. The company’s pipeline includes...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2014
• Employees: 16
• Stock Exchange: OTCMKTS
• Ticker Symbol: NTBLQ

Financial Performance

In 2023, Notable Labs's revenue was $310,000, an increase of 3775.00% compared to the previous year's $8,000. Losses were -$11.26 million, -21.82% less than in 2022.